Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Research Report – Segmented By Business Mode, Vendors, Type of Delivery & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 688
Pages: 145

Asia-Pacific VNA & PACS Market Size (2024 to 2029)

The VNA & PACS market size in Asia-Pacific is predicted to be worth USD 0.87 bn by 2029 from USD 0.63 bn in 2024, growing at a CAGR of 6.71% from 2024 to 2029.

The increasing demand for standard-based storage, lifecycle management solutions, and disaster recovery is majorly driving the APAC region's VNA and PACS market growth.

Also, the growing population contributes to the rise of the VNA and PACS markets in this region. In addition, other factors such as rising medical imaging investments, and technological advancements in diagnostic imaging modalities are driving the VNA and PACS market. The adoption of modern technologies for better administration also boosts the VNA and PACS market’s growth rate in the Asia-Pacific region.

On the other hand, the growing demand for advanced imaging equipment, rapidly growing big data in healthcare, and growing healthcare IT and HER adoption are expected to boost the market growth. In addition, the market players in the region are implementing various strategies such as new market strategies and partnerships, which are expected to generate profitable growth prospects for the vendor-neutral archive and PACS market. Moreover, VNA technology's advantages demand is expected to provide lucrative growth opportunities for market participants. 

Policy reforms and government support in various countries are expected to raise market demand and expand growth prospects for the leading players in the vendor-neutral archive and PACS market. Furthermore, during the forecast period, the integration of cloud technologies for VNA products and adopting a holistic approach to providing a higher quality of healthcare are expected to give profitable chances for the VNA and PACS market to develop in the APAC region.However, lack of awareness of the VNA concepts and budgetary restrictions are primarily limiting the market’s expansion to some extent.

This research report on the Asia-Pacific VNA & PACS market has been segmented and sub-segmented into the following categories.

Asia-Pacific VNA & PACS Market Analysis By Business Mode

  • Enterprise
  • Departmental
  • Vendors
  • Independent Vendors
  • Commercial Vendors

Asia-Pacific VNA & PACS Market Analysis By Mode of Delivery

  • On-Premise VNA
  • Hybrid VNA
  • Complete Cloud-Hosted VNA

Asia-Pacific VNA & PACS Market Analysis By Business Mode

  • Enterprise
  • Departmental

Asia-Pacific VNA & PACS Market Analysis By Components

  • Hardware
  • Software

Asia-Pacific VNA & PACS Market Analysis By Type of Instruments

  • X-ray
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Nuclear Imaging
  • Ultrasound

Asia-Pacific VNA & PACS Market Analysis By Mode of Delivery

  • Mobile Based
  • Cloud-Based
  • Client-Server Based

Asia-Pacific VNA & PACS Market Analysis By Country

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The Asia Pacific is projected to account for a promising share in the global VNA and PACS market during the forecast period.

The PACS is one of the most commonly used technologies in hospitals around the region. In developed countries such as Japan, PACS is utilized in more than 80% of hospitals. The scope is apparent in developing Asia Pacific countries such as India and China. Healthcare institutions in these countries have shifted from multiple services to integrated systems for exchanging and storing medical images. These countries are rapidly adopting PACS due to rising healthcare costs and growing awareness of picture archiving and communication systems. Also, China and India are the region’s most populated countries, contributing to increasing demand and national and state-level healthcare. IT policies in China, Japan, and Australia. Price sensitivity, on the other hand, has limited the market’s expansion in this region. Indonesia, Vietnam, and Malaysia are among the market’s most promising companies. Due to government-supported nationwide healthcare changes in Australia, China, and Japan are the following promising places for adopting this technology.

This region offers substantial opportunities for the VNA & PACS market, with China and India being the most populous countries contributing to the increasing demand. Also, due to the nation and state-wide healthcare, IT policies in China, Japan, and Australia. However, price sensitivity has considerably hindered the growth of the market in this region. Indonesia, Vietnam, and Malaysia are some of the promising players in this market.

China is anticipated to register a prominent share in the APAC market during the forecast period. In China, both the government and private enterprises have made significant investments in imaging. Still, the focus is on improving access to healthcare and providing healthcare to those who are underserved. However, the healthcare experience might be complicated with long queues and delays outside of the country’s developed cities.

KEY MARKET PLAYERS

A few of the promising companies operating in the APAC VNA & PACS Market profiled in this report are Acuo Technologies, which leads the global VNA market, followed by Agfa HealthCare, Carestream Health, Dell, Inc., BridgeHead Software, Fujifilm Corporation, Merge Health, GE Healthcare, Philips Healthcare, Siemens Healthcare, McKesson Corporation, and TeraMedica (U.S.).

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample